source
- Seawolf Therapeutics raises $100M and secures up to $1.2B partnership with Sanofi for redosable DNA medicinesSeawolf Therapeutics announced a $100 million Series A financing backed by investors including Novartis Venture Fund, Eli Lilly, CRISPR Therapeutics and others. The company also disclosed a multi‑…
- Choosing the Right AI Infrastructure Is Key to Accelerating Future Drug DiscoveriesScientific AI is reshaping drug discovery by allowing developers to predict molecule behavior and design new compounds using models trained on protein structures, genomic data, and experimental res…